3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025

DexCom - DexCom launched a new CGM device called Stelo, targeting non-insulin users and requiring no prescription, potentially tapping into growing health awareness [1] - DexCom's growth rate was in low single digits last year, with stock down 37% due to salesforce restructuring, but improvement in growth could lead to a rally in 2025 [3] - Investors are bearish on DexCom due to GLP-1 weight loss drugs, assuming reduced need for CGMs as diabetics lose weight, though this may not reflect the broader market [10] Celsius Holdings - Celsius Holdings faced a 31% revenue drop in Q3 2024, attributed to PepsiCo reducing inventory, raising concerns about demand [7][8] - The company's stock lost over half its value in 2024, but potential remains in the sugar-free energy market if growth resumes [8][9] - Investors may wait for confirmation of a one-time issue before considering Celsius as a rebound candidate [9] Nike - Nike's market capitalization dropped 30% in 2024 due to slowing demand, with revenue down 8% in the latest quarter [5][11] - The company has a new CEO focused on revitalizing the brand and improving sales performance [11] - Nike's stock is trading near its 52-week low, potentially offering a buying opportunity for bullish investors [4]